Warning: This security is no longer trading.
Company to File Chapter 11 Bankruptcy
Orexigen Therapeutics, Inc. (OREX): Price and Financial Metrics
OREX Price/Volume Stats
| Current price | $0.22 | 52-week high | $3.81 |
| Prev. close | $0.34 | 52-week low | $0.17 |
| Day low | $0.22 | Volume | 3,735,400 |
| Day high | $0.32 | Avg. volume | 1,162,597 |
| 50-day MA | $0.82 | Dividend yield | N/A |
| 200-day MA | $1.73 | Market Cap | 4.16M |
OREX Stock Price Chart Interactive Chart >
Orexigen Therapeutics, Inc. (OREX) Company Bio
Orexigen Therapeutics, Inc. focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. The company was founded in 2002 and is based in La Jolla, California.
OREX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...